Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 6/20 | 0.79 |
| ▸ | FBP1 | P09467 | 2/20 | 0.46 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7619255 | 0.95 | NLRP3 (0.72) | NLRP3FBP1GSTO1 | |
| SCHEMBL6513806 | 0.88 | NLRP3 (1.00) | NLRP3FBP1GSTO1 | |
| SCHEMBL7144442 | 0.87 | NLRP3 (0.85) | NLRP3FBP1 | |
| SCHEMBL7139456 | 0.85 | NLRP3 (0.82) | NLRP3FBP1 | |
| SCHEMBL7144307 | 0.84 | NLRP3 (0.80) | NLRP3FBP1 | |
| SCHEMBL7139811 | 0.82 | NLRP3 (0.71) | NLRP3FBP1GSTO1 | |
| SCHEMBL7145814 | 0.82 | NLRP3 (0.76) | NLRP3FBP1 | |
| SCHEMBL7137330 | 0.82 | NLRP3 (0.76) | NLRP3FBP1 | |
| SCHEMBL6555763 | 0.82 | NLRP3 (0.76) | NLRP3FBP1 | |
| SCHEMBL7620133 | 0.81 | NLRP3 (0.74) | NLRP3FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0964849-B1 | SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY | PFIZER (US) | 2003-06-04 | — | — | EP | disclosed |
| EP-1270554-A1 | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity | PFIZER INC. (US) | 2003-01-02 | — | — | EP | disclosed |
| EP-1270565-A1 | 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives | PFIZER INC. (US) | 2003-01-02 | — | — | EP | disclosed |
| US-6433009-B1 | TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS | PFIZER INC | 2002-08-13 | — | — | US | disclosed |
| US-6166064-A | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity | PFIZER INC (US) | 2000-12-26 | — | — | US | disclosed |